BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21029083)

  • 1. Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center.
    Leonardi M; Raggi A; Bussone G; D'Amico D
    Headache; 2010 Nov; 50(10):1576-86. PubMed ID: 21029083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disability and quality of life in different primary headaches: results from Italian studies.
    Bussone G; Usai S; Grazzi L; Rigamonti A; Solari A; D'Amico D
    Neurol Sci; 2004 Oct; 25 Suppl 3():S105-7. PubMed ID: 15549514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting disability and quality of life in a community-based sample of women with migraine headache.
    Kolotylo CJ; Broome ME
    Pain Manag Nurs; 2000 Dec; 1(4):139-51. PubMed ID: 11709867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS).
    Blumenfeld AM; Varon SF; Wilcox TK; Buse DC; Kawata AK; Manack A; Goadsby PJ; Lipton RB
    Cephalalgia; 2011 Feb; 31(3):301-15. PubMed ID: 20813784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Headache prophylaxis with BoNTA: patient characteristics.
    Silberstein SD; Marmura MJ; Shaw J; Yu S
    Headache; 2010 Jan; 50(1):63-70. PubMed ID: 19549156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and psychiatric co‑morbidity in Indian migraine patients: a headache clinic sample.
    Sharma K; Remanan R; Singh S
    Neurol India; 2013; 61(4):355-9. PubMed ID: 24005724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study.
    D'Amico D; Solari A; Usai S; Santoro P; Bernardoni P; Frediani F; De Marco R; Massetto N; Bussone G;
    Cephalalgia; 2006 Jun; 26(6):691-6. PubMed ID: 16686908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbid migraine is associated with a negative impact on quality of life in patients with major depression.
    Hung CI; Liu CY; Fuh JL; Juang YY; Wang SJ
    Cephalalgia; 2006 Jan; 26(1):26-32. PubMed ID: 16396663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impacts of migraine, anxiety disorders, and chronic depression on quality of life in psychiatric outpatients with major depressive disorder.
    Hung CI; Wang SJ; Yang CH; Liu CY
    J Psychosom Res; 2008 Aug; 65(2):135-42. PubMed ID: 18655858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).
    De Diego EV; Lanteri-Minet M
    Cephalalgia; 2005 Mar; 25(3):184-90. PubMed ID: 15689193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of depressive symptoms as predictor of impairment of quality of life in chronic migraine: comparison with episodic migraine.
    Canuet L; Ishii R; Fernandez-Concepcion O; Iwase M; Takeda M
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):738-40. PubMed ID: 19068012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian adolescents with migraine: impaired health-related quality of life.
    Brna P; Gordon K; Dooley J
    J Child Neurol; 2008 Jan; 23(1):39-43. PubMed ID: 18079320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey.
    Lucas C; Géraud G; Valade D; Chautard MH; Lantéri-Minet M
    Headache; 2006 May; 46(5):715-25. PubMed ID: 16643573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migraine: a better way to recognize and treat it.
    Landy SH; Kwong WJ; Hutchinson S; Roselli A; Burch SP
    J Fam Pract; 2006 Dec; 55(12):1038-47. PubMed ID: 17137539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvements in health-related quality of life with sumatriptan treatment for migraine.
    Jhingran P; Cady RK; Rubino J; Miller D; Grice RB; Gutterman DL
    J Fam Pract; 1996 Jan; 42(1):36-42. PubMed ID: 8537803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key concepts of migraine postdrome: a qualitative study to develop a post-migraine questionnaire.
    Ng-Mak DS; Fitzgerald KA; Norquist JM; Banderas BF; Nelsen LM; Evans CJ; Healy CG; Ho TW; Bigal M
    Headache; 2011 Jan; 51(1):105-17. PubMed ID: 21198571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic migraine: a prospective descriptive clinical study in a headache center population.
    Beckmann YY; Seçil Y; Kendir AI; Başoğlu M
    Pain Pract; 2009; 9(5):380-4. PubMed ID: 19622107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Headache disability among adolescents: a student population-based study.
    Fuh JL; Wang SJ; Lu SR; Liao YC; Chen SP; Yang CY
    Headache; 2010 Feb; 50(2):210-8. PubMed ID: 19804389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life and health-related disability in children with migraine.
    Ferracini GN; Dach F; Speciali JG
    Headache; 2014 Feb; 54(2):325-34. PubMed ID: 24512577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.